Ceftriaxone and Tabrecta drug interactions - a phase IV clinical study of FDA data
Summary:
The phase IV clinical study analyzes what interactions people have when they take Ceftriaxone and Tabrecta. It is created by eHealthMe based on reports of 1 person who takes the same drugs from the FDA, and is updated regularly.
What is Ceftriaxone?
Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.
What is Tabrecta?
Tabrecta has active ingredients of capmatinib hydrochloride. eHealthMe is studying from 2,095 Tabrecta users. Check the latest studies of Tabrecta.
1 person who takes Ceftriaxone and Tabrecta together, and has interactions is studied.
What are the common drug interactions of Ceftriaxone and Tabrecta, by gender? *:
female:
- Malignant neoplasm progression (cancer tumour came back)
- Non-small cell lung cancer stage iv
- Platelet count decreased
- Urinary tract infection
male:
n/a
What are the common drug interactions of Ceftriaxone and Tabrecta, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Malignant neoplasm progression (cancer tumour came back)
- Non-small cell lung cancer stage iv
- Platelet count decreased
- Urinary tract infection
* Approximation only. Some reports may have incomplete information.
Do you take Ceftriaxone and Tabrecta?
- Personalize this study to your gender, age, symptoms and drugs (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ceftriaxone (40,991 reports)
- Tabrecta (2,095 reports)
Browse all drug interactions of Ceftriaxone and Tabrecta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ceftriaxone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tabrecta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ceftriaxone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tabrecta and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ceftriaxone sodium and capmatinib hydrochloride (the active ingredients of Ceftriaxone and Tabrecta, respectively), and Ceftriaxone and Tabrecta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Probiotics cause Nausea? - a second ago
- Could Augmentin '125' cause Lung Neoplasm? - a second ago
- Lipitor and Wide-Complex Tachycardia for Women aged 60+ - 4 seconds ago
- Lipitor and V Tach for Women aged 60+ - 4 seconds ago
- Gaviscon vs. Gravol, side effect and effectiveness comparison - 4 seconds ago
- Lipitor and Tachycardia - Ventricular for Women aged 60+ - 4 seconds ago
- Lipitor and Ventricular Tachycardia for Women aged 60+ - 5 seconds ago
- Rheumatoid Arthritis and Abscess Limb - 6 seconds ago
- Hydroxyzine Hydrochloride vs. Cymbalta, side effect and effectiveness comparison - 7 seconds ago
- Could Fish Oil cause Gait Disturbance? - 12 seconds ago